BNP-7787 (BioNumerik/Baxter Oncology/Grelan)
- PMID: 14730469
BNP-7787 (BioNumerik/Baxter Oncology/Grelan)
Abstract
BioNumerik Pharmacology Inc, Baxter Oncology GmbH (formerly ASTA Medica AG) and Grelan Pharmaceutical Co Ltd are developing BNP-7787 for the potential reduction of toxicity associated with cisplatin and carboplatin treatment in cancer patients.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical